⌘K

Login Start Free

Home/Filings/4/0001209191-19-025626

4//SEC Filing

LAPALME PIERRE 4

Accession 0001209191-19-025626

CIK 0001516479other

View on SEC.gov Company Profile

Filed

Apr 22, 8:00 PM ET

Accepted

Apr 23, 7:09 PM ET

Size

11.4 KB

Accession

0001209191-19-025626

Insider Transaction Report

Form 4

Period: 2018-03-05

Insys Therapeutics, Inc.INSY

Director

Transactions

Award
Common Stock
2018-03-05+4,000→ 10,000 total
Award
Employee Stock Option (right to buy)
2018-03-05+16,000→ 16,000 total
Exercise: $8.06Exp: 2028-03-04→ Common Stock (16,000 underlying)
Award
Common Stock
2019-03-04+8,083→ 18,083 total
Award
Employee Stock Option (right to buy)
2019-03-04+20,935→ 20,935 total
Exercise: $6.36Exp: 2029-03-03→ Common Stock (20,935 underlying)

Holdings

CommonStock
(indirect: By Spouse)
1,000

Footnotes (2)

[F1]The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 5, 2021.
[F2]The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 4, 2022.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Insys Therapeutics, Inc.

CIK 0001516479

Entity typeother

Related Parties

1

filerCIK 0001114913

Filing Metadata

Form type: 4
Filed: Apr 22, 8:00 PM ET
Accepted: Apr 23, 7:09 PM ET
Size: 11.4 KB

View on SEC.gov